TRDA Latest Press Releases

-- January 8, 2026 --

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases Globe Newswire 7:00 AM

-- December 17, 2025 --

Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 7:00 AM

-- December 4, 2025 --

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- November 6, 2025 --

Entrada Therapeutics Reports Third Quarter 2025 Financial Results Globe Newswire 7:00 AM

-- October 28, 2025 --

Entrada Therapeutics to Present at Upcoming Investor Conferences Globe Newswire 7:00 AM

-- September 5, 2025 --

Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program Globe Newswire 7:00 AM

-- September 2, 2025 --

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software